Navigation Links
Abbey Color Inc. and Mexicana de Extractos International, S.A. de C.V. Announce Joint Venture Abbymex
Date:5/13/2010

The joint venture Abbymex is announced by Abbey Color Inc. and Mexicana de Extractos International, S.A. de C.V. to provide a consistent supply of logwood extract used in the production of hematoxylin and hematine. Hematoxylin is a key ingredient in stains used by biological laboratories for Pap smear tests and hematine is used to dye medical sutures. Abbey Color is the world’s largest manufacturer of both hematoxylin and hematine.

Philadelphia, PA (PRWEB) May 13, 2010 -- Abbey Color Inc., located in Philadelphia, Pennsylvania, USA, announces a joint venture with Mexicana de Extractos International, S.A. de C.V., located in Campeche, Mexico. Mexicana de Extractos has supplied logwood extract to Abbey Color Inc. for their Hematoxylin and Hematine production for over thirty years and the newly formed joint venture, registered as Abbymex, is being built on the strong foundation of mutual respect and trust that has evolved over the years because of the high principles espoused by both companies.

“We are very excited about this venture,” explained Roger Nielsen, President and Owner of Abbey Color Inc. “This investment continues our strategic plan to meet the critical need for Hematoxylin and Hematine in the health industry worldwide. This is a responsibility we take very seriously, and we have demonstrated our commitment through our substantial investment in this joint venture. We are pleased to partner with Mexicana de Extractos, a company of excellent reputation and one which shares our values and our vision. As a result of this venture, our customers throughout the world can purchase their materials, confident in the knowledge that problems with periodic shortages will now be a thing of the past. In accordance with the integrity principles of our combined companies, we have also resolved to maintain a consistent and reasonable pricing structure, as we have done in the past.”

This venture signifies both parties’ dedication to continue supplying hematoxylin to the Hemotoxylin and Eosin Y (H&E) stain markets in North America and throughout the world. Agreements within the formulation of the Abbymex joint venture will ensure continuous and consistent supply of logwood extract to the Abbey Color facility in Philadelphia as to maintain uninterrupted production and inventory building of hematoxylin and hematine.

About Abbey Color Inc.
Abbey Color is a premier dye manufacturer and supplier of industrial dyes, dye precursors and colorants serving various domestic and international markets ranging from healing practices to industrial uses. Abbey Color is the world’s leading manufacturer of hematoxylin and is the only dye manufacturer in the world that makes both hematoxylin and eosin Y. Abbey Color is a supplier to the makers of various biological stain products and hematoxylin is always in stock. Abbey Color's hematoxylin is certified by the Biological Stain Commission (BSC). Hematoxylin is the key ingredient in stains used by biological laboratories and pathologists for Pap smear tests using H&E stain and other procedures. Hematine is used for the dyeing of silk that is used in medical sutures. Abbey Color is a ChemStewards® certified facility.

Contact Abbey Color
For more information or to inquire about Abbey Color’s products and services, including hematoxylin, hematine, logwood extract and biological stain products, please call 215-739-9960 or visit the Abbey Color website at www.AbbeyColor.com.

###

Read the full story at http://www.prweb.com/releases/abbymex/joint-venture/prweb3995624.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Exploring gender differences in colorectal cancer screenings
2. Homewatch CareGivers Show in Colorado is Next for SilverStone Group's In-Home Care Team
3. Plastics Color Corporation Expands Into California
4. Three Genes Linked to Variations in Eye Color
5. FDG-PET/CT plays a definite role in detecting colorectal cancer recurrences
6. Investigators examine colorectal cancer screening methods among diverse populations
7. Researchers show that nitric oxide-donating naproxen can boost colorectal cancer prevention
8. Association of fiber and colorectal cancer risk differs depending on dietary assessment method
9. UAB researchers find 4 biomarkers important in colorectal cancer treatment prognosis
10. Hispanics live in areas with limited capacity for colorectal cancer screening
11. Leukemia-related protein 16 and colorectal carcinoma
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Abbey Color Inc. and Mexicana de Extractos International, S.A. de C.V. Announce Joint Venture Abbymex 
(Date:3/24/2017)... ... March 24, 2017 , ... The iaedp Foundation, the ... medical professionals caring for those suffering from the full spectrum of disordered eating, announced ... eating disorders professionals from nearly all 50 states and several countries converged on the ...
(Date:3/24/2017)... ... March 24, 2017 , ... Northridge ... offering treatments for sleep apnea and TMJ at their office. TMJ, or temporomandibular ... specifically the obstructive type, is increasingly being treated at dental offices with newly ...
(Date:3/24/2017)... ... March 24, 2017 , ... Empower Brokerage, located in Southlake, ... leads programs. , In February, 2017, Empower Brokerage introduced their new “Performance Partners” ... designed to teach how to maximize their sales efforts, as well as how ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The Communion of ... people of God in congregations across the United States. “The Communion of ... in 1964 who has served congregations in seven states throughout his long career ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... services to their communities, 16 more public health departments have been awarded national ... bring another 4.5 million people into the expanding network of communities across the ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... -- Research and Markets has announced the addition of ... to 2025" report to their offering. ... The Global Cryostat Market is poised ... decade to reach approximately $3.5 billion by 2025. This ... given segments on global as well as regional levels presented in ...
(Date:3/23/2017)... 2017 The key factors driving the ... population, accelerating economic growth and increasing healthcare expenditure. Some of ... life expectancy of ESRD patients, rising demand for home PD ... expansion of the market is hindered by high treatment costs ... ...
(Date:3/23/2017)... 23, 2017  Transportation Insight, a multi-modal lead logistics ... chain management firm with expertise serving clients in the ... Rick Zaffarano was named a 2017 Food ... by the only publication exclusively dedicated to covering the ... "Rick has brought to Transportation Insight a ...
Breaking Medicine Technology: